Regression models and life-tables ,
, Discussion on Professor Cox's Paper, Journal of the Royal Statistical Society: Series B (Methodological), vol.34, issue.2, pp.202-220, 1972.
Limitations of hazard ratios in clinical trials, European Heart Journal, vol.40, issue.17, pp.1378-1383, 2018. ,
Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results, JAMA Cardiology, vol.2, issue.11, p.1179, 2017. ,
On the restricted mean survival time curve in survival analysis, Biometrics, vol.72, issue.1, pp.215-221, 2015. ,
Estimating the Long-Term Treatment Benefits of Sacubitril?Valsartan, New England Journal of Medicine, vol.373, issue.23, pp.2289-2290, 2015. ,
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome, BMC Medical Research Methodology, vol.13, issue.1, p.152, 2013. ,
Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease, Circulation, vol.138, issue.15, pp.1599-1601, 2018. ,
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis, Journal of Clinical Oncology, vol.32, issue.22, pp.2380-2385, 2014. ,
Estimated Long-Term Survival With Eplerenone, Journal of the American College of Cardiology, vol.73, issue.18, pp.2357-2359, 2019. ,